Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Matrix M”

62 trials

Showing 20 of 62 results

Testing effectiveness (Phase 2)Study completedNCT03026348
What this trial is testing

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

Who this might be right for
Respiratory Syncytial Viruses
Novavax 300
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Testing effectiveness (Phase 2)Study completedNCT04533399
What this trial is testing

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 4,422
Testing effectiveness (Phase 2)Active Not RecruitingNCT07074665
What this trial is testing

Dose Finding Trial of R21/Matrix-M in School Children

Who this might be right for
Malaria (Plasmodium Falciparum)
University of Oxford 40
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Large-scale testing (Phase 3)Study completedNCT07079670
What this trial is testing

Safety and Immunogenicity of NVX-CoV2705

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sanofi 676
Testing effectiveness (Phase 2)Study completedNCT05252845
What this trial is testing

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Who this might be right for
Malaria,Falciparum
University of Oxford 127
Testing effectiveness (Phase 2)Ended earlyNCT03947190
What this trial is testing

Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults

Who this might be right for
Malaria,Falciparum
University of Oxford 80
Testing effectiveness (Phase 2)Looking for participantsNCT06879327
What this trial is testing

Infant Malaria Vaccine Schedule Optimization

Who this might be right for
Malaria Vaccines
PATH 964
Early research (Phase 1)Study completedNCT01669512
What this trial is testing

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

Who this might be right for
MalariaMatrix M
University of Oxford 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05380388
What this trial is testing

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Who this might be right for
Plasmodium Vivax InfectionMalaria Vaccine
University of Oxford 36
Early research (Phase 1)Study completedNCT05913973
What this trial is testing

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 105
Early research (Phase 1)Study completedNCT05135273
What this trial is testing

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali

Who this might be right for
Malaria,Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Study completedNCT05357560
What this trial is testing

Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

Who this might be right for
Malaria, Plasmodium Falciparum
University of Oxford 107
Testing effectiveness (Phase 2)WithdrawnNCT07208760
What this trial is testing

L9LS-R21 Interaction

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02925403
What this trial is testing

Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant

Who this might be right for
Malaria
University of Oxford 13
Large-scale testing (Phase 3)Study completedNCT04120194
What this trial is testing

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Who this might be right for
Influenza, Human
Novavax 2,654
Not applicableUnknownNCT02557906
What this trial is testing

Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)

Who this might be right for
Breast NeoplasmsBreast Diseases
King's College London 209
Testing effectiveness (Phase 2)Active Not RecruitingNCT07183371
What this trial is testing

Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Who this might be right for
Malaria,Falciparum
University of Oxford 360
Early research (Phase 1)Looking for participantsNCT06958198
What this trial is testing

Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

Who this might be right for
Malaria,Falciparum
University of Oxford 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation